-
1
-
-
0034754477
-
Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial
-
Sandborn W.J., et al. Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial. Gastroenterology 2001, 121:1088-1094.
-
(2001)
Gastroenterology
, vol.121
, pp. 1088-1094
-
-
Sandborn, W.J.1
-
2
-
-
4644325814
-
CDP571, a humanised monoclonal antibody to tumour necrosis factor alpha, for moderate to severe Crohn's disease: a randomised, double blind, placebo controlled trial
-
Sandborn W.J., et al. CDP571, a humanised monoclonal antibody to tumour necrosis factor alpha, for moderate to severe Crohn's disease: a randomised, double blind, placebo controlled trial. Gut 2004, 53:1485-1493.
-
(2004)
Gut
, vol.53
, pp. 1485-1493
-
-
Sandborn, W.J.1
-
3
-
-
66849137185
-
-
European Medicines Agency, Accessed 12 July 2008
-
Refusal assessment report for Cimzia 2008, European Medicines Agency, Accessed 12 July 2008.
-
(2008)
Refusal assessment report for Cimzia
-
-
-
6
-
-
70449596780
-
SONIC: a randomized, double-blind, controlled trial comparing infliximab and infliximab plus azathioprine to azathioprine in patients with Crohn's disease naive to immunomodulators and biologic therapy
-
abstract
-
Colombel J.F., et al. SONIC: a randomized, double-blind, controlled trial comparing infliximab and infliximab plus azathioprine to azathioprine in patients with Crohn's disease naive to immunomodulators and biologic therapy. JCC-J Crohn's Col 2009, 3:S45-S46. abstract.
-
(2009)
JCC-J Crohn's Col
, vol.3
-
-
Colombel, J.F.1
-
7
-
-
39449085441
-
Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial
-
D'Haens G., et al. Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial. Lancet 2008, 371:660-667.
-
(2008)
Lancet
, vol.371
, pp. 660-667
-
-
D'Haens, G.1
-
8
-
-
32944461717
-
Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease
-
Rutgeerts P., et al. Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease. Gastrointest Endosc 2006, 63:433-442.
-
(2006)
Gastrointest Endosc
, vol.63
, pp. 433-442
-
-
Rutgeerts, P.1
-
9
-
-
70350172248
-
Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn's disease
-
Schnitzler F., et al. Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn's disease. Inflamm Bowel Dis 2009, 15:1295-1301.
-
(2009)
Inflamm Bowel Dis
, vol.15
, pp. 1295-1301
-
-
Schnitzler, F.1
-
10
-
-
75049083870
-
Endoscopic improvement in patients with active Crohn's disease treated with certolizumab pegol: first results of the MUSIC clinical trial
-
Hébuterne X., et al. Endoscopic improvement in patients with active Crohn's disease treated with certolizumab pegol: first results of the MUSIC clinical trial. Gut 2008, 57(Suppl II):A15.
-
(2008)
Gut
, vol.57
, Issue.SUPPL 2
-
-
Hébuterne, X.1
-
11
-
-
70350684087
-
Adalimumab Induces and Maintains Mucosal Healing in Patients with Moderate to Severe Ileocolonic Crohn's Disease - First Results of the Extend Trial
-
abstract
-
Rutgeerts P., et al. Adalimumab Induces and Maintains Mucosal Healing in Patients with Moderate to Severe Ileocolonic Crohn's Disease - First Results of the Extend Trial. Gastroenterology 2009, 136(Suppl 1):751e. abstract.
-
(2009)
Gastroenterology
, vol.136
, Issue.SUPPL 1
-
-
Rutgeerts, P.1
-
12
-
-
34547503869
-
Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort
-
Frøslie K.F., et al. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort. Gastroenterology 2007, 133:412-422.
-
(2007)
Gastroenterology
, vol.133
, pp. 412-422
-
-
Frøslie, K.F.1
-
13
-
-
75449106111
-
Mucosal Healing Predicts Sustained Clinical Remission in Patients with Early-Stage Crohn's Disease
-
Electronic publication ahead of print
-
Baert F., et al. Mucosal Healing Predicts Sustained Clinical Remission in Patients with Early-Stage Crohn's Disease. Gastroenterology Oct. 7 2009, Electronic publication ahead of print.
-
(2009)
Gastroenterology
-
-
Baert, F.1
-
14
-
-
0033529049
-
Infliximab for the treatment of fistulas in patients with Crohn's disease
-
Present D.H., et al. Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med 1999, 340:1398-1405.
-
(1999)
N Engl J Med
, vol.340
, pp. 1398-1405
-
-
Present, D.H.1
-
15
-
-
10744221312
-
Infliximab maintenance therapy for fistulizing Crohn's disease
-
Sands B.E., et al. Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med 2004, 350:876-885.
-
(2004)
N Engl J Med
, vol.350
, pp. 876-885
-
-
Sands, B.E.1
|